Apolipoproteins in vascular biology and atherosclerotic disease
A Mehta, MD Shapiro - Nature Reviews Cardiology, 2022 - nature.com
Apolipoproteins are important structural components of plasma lipoproteins that influence
vascular biology and atherosclerotic disease pathophysiology by regulating lipoprotein …
vascular biology and atherosclerotic disease pathophysiology by regulating lipoprotein …
[HTML][HTML] Molecular interactions at the surface of extracellular vesicles
Extracellular vesicles such as exosomes, microvesicles, apoptotic bodies, and large
oncosomes have been shown to participate in a wide variety of biological processes and are …
oncosomes have been shown to participate in a wide variety of biological processes and are …
[HTML][HTML] Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
[HTML][HTML] Dyslipidemia in obesity: mechanisms and potential targets
B Klop, JWF Elte, M Castro Cabezas - Nutrients, 2013 - mdpi.com
Obesity has become a major worldwide health problem. In every single country in the world,
the incidence of obesity is rising continuously and therefore, the associated morbidity …
the incidence of obesity is rising continuously and therefore, the associated morbidity …
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
AB Jørgensen, R Frikke-Schmidt… - … England Journal of …, 2014 - Mass Medical Soc
Background High plasma levels of nonfasting triglycerides are associated with an increased
risk of ischemic cardiovascular disease. Whether lifelong low levels of nonfasting …
risk of ischemic cardiovascular disease. Whether lifelong low levels of nonfasting …
Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia
D Gaudet, VJ Alexander, BF Baker… - … England Journal of …, 2015 - Mass Medical Soc
Background Apolipoprotein C-III (APOC3) is a key regulator of plasma triglyceride levels.
Elevated triglyceride levels are associated with a risk of adverse cardiovascular events and …
Elevated triglyceride levels are associated with a risk of adverse cardiovascular events and …
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
H Noels, M Lehrke, R Vanholder… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) induces modifications in lipid and lipoprotein metabolism and
homeostasis. These modifications can promote, modulate and/or accelerate CKD and …
homeostasis. These modifications can promote, modulate and/or accelerate CKD and …
RNA interference therapy targeting apolipoprotein C-III in hypertriglyceridemia
Abstract Background Apolipoprotein C-III (APOC3) inhibits triglyceride clearance by
reducing lipoprotein lipase–mediated hydrolysis and hepatocyte uptake of triglyceride-rich …
reducing lipoprotein lipase–mediated hydrolysis and hepatocyte uptake of triglyceride-rich …
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
A long-standing association exists between elevated triglyceride levels and cardiovascular
disease*(CVD). 1, 2 However, the extent to which triglycerides directly promote CVD or …
disease*(CVD). 1, 2 However, the extent to which triglycerides directly promote CVD or …
Targeting APOC3 in the familial chylomicronemia syndrome
D Gaudet, D Brisson, K Tremblay… - … England Journal of …, 2014 - Mass Medical Soc
The familial chylomicronemia syndrome is a genetic disorder characterized by severe
hypertriglyceridemia and recurrent pancreatitis due to a deficiency in lipoprotein lipase …
hypertriglyceridemia and recurrent pancreatitis due to a deficiency in lipoprotein lipase …